Stock Price
709.20
Daily Change
5.60 0.80%
Monthly
1.60%
Yearly
18.52%
Q1 Forecast
704.56

argenx SE reported $344.26M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AstraZeneca USD 2.33B 207M Dec/2025
Galapagos EUR -202.11M 96.36M Sep/2025
Genmab DKK 336M 141M Jun/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 126.96M 9.9M Sep/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Qiagen NV USD 107.83M 22.21M Dec/2025
UCB EUR 857M 649M Dec/2024